Business Description
Changjiang Pharmaceutical Group Co Ltd
ISIN : CNE100001XN8
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.01 | |||||
Debt-to-Equity | 56.1 | |||||
Debt-to-EBITDA | -1.02 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -0.63 | |||||
Beneish M-Score | -1.76 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.5 | |||||
3-Year Book Growth Rate | -36.9 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 18.53 | |||||
9-Day RSI | 28.19 | |||||
14-Day RSI | 36.95 | |||||
6-1 Month Momentum % | 164.2 | |||||
12-1 Month Momentum % | -16.73 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1 | |||||
Quick Ratio | 0.97 | |||||
Days Inventory | 80.22 | |||||
Days Sales Outstanding | 2073.39 | |||||
Days Payable | 512.93 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 3.32 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 13.81 | |||||
Operating Margin % | -21.01 | |||||
Net Margin % | -242.42 | |||||
FCF Margin % | -79.35 | |||||
ROE % | -309.32 | |||||
ROA % | -19.94 | |||||
ROIC % | -3.09 | |||||
ROC (Joel Greenblatt) % | -60.54 | |||||
ROCE % | -51.58 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 7.19 | |||||
PB Ratio | 142.25 | |||||
EV-to-EBIT | -3.63 | |||||
EV-to-EBITDA | -3.63 | |||||
EV-to-Revenue | 10.26 | |||||
EV-to-FCF | -14.87 | |||||
Price-to-Median-PS-Value | 2.31 | |||||
Earnings Yield (Greenblatt) % | -27.55 | |||||
FCF Yield % | -11.01 | |||||
Forward Rate of Return (Yacktman) % | 20.96 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Changjiang Pharmaceutical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 276.7 | ||
EPS (TTM) (Â¥) | -1.915 | ||
Beta | 1.19 | ||
Volatility % | 126.29 | ||
14-Day RSI | 36.95 | ||
14-Day ATR (Â¥) | 0.437182 | ||
20-Day SMA (Â¥) | 6.7645 | ||
12-1 Month Momentum % | -16.73 | ||
52-Week Range (Â¥) | 2.24 - 8.14 | ||
Shares Outstanding (Mil) | 350.34 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Changjiang Pharmaceutical Group Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Changjiang Pharmaceutical Group Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Changjiang Pharmaceutical Group Co Ltd Frequently Asked Questions
What is Changjiang Pharmaceutical Group Co Ltd(SZSE:300391)'s stock price today?
When is next earnings date of Changjiang Pharmaceutical Group Co Ltd(SZSE:300391)?
Does Changjiang Pharmaceutical Group Co Ltd(SZSE:300391) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |